论文部分内容阅读
头孢比普作为广谱头孢菌素,对耐甲氧西林金葡菌(MRSA)所致复杂性皮肤软组织感染(cSSSI)的疗效不逊于万古霉素和头孢他啶的联合用药方案。该临床试验分析了头孢比普治疗cSSSI的疗效与TMIC的百分比(游离血药浓度超过MIC持续的时间占给药间隔时间百分比)的关系。该项研究中309例
Cefpipib as a broad spectrum cephalosporin has no adverse effect on the combination of vancomycin and ceftazidime for complicated skin and soft tissue infections (cSSSI) caused by methicillin-resistant Staphylococcus aureus (MRSA). The clinical trial analyzed the relationship between the efficacy of cefpipil in the treatment of cSSSI and the percentage of TMIC (free plasma concentration over MIC persisted over the dosing interval). 309 cases in this study